Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 18-Sep-24 4:31 PM View:  | Singular Genomics Systems, ... (OMIC) | 18-Sep-24 | Purchase | 32,000 | $17.21 | $550,720.00 | 9% 340.0K to 372.0K | |
| 18-Sep-24 4:31 PM View: | Singular Genomics Systems, ... (OMIC) | 17-Sep-24 | Purchase | 40,000 | $15.33 | $613,200.00 | 13% 300.0K to 340.0K | |
| 18-Sep-24 4:31 PM View: | Singular Genomics Systems, ... (OMIC) | 16-Sep-24 | Purchase | 50,416 | $12.74 | $642,300.00 | 20% 249.58K to 300.0K | |
| 02-Feb-24 4:00 PM View: | Rain Oncology Inc. (RAIN) | 26-Jan-24 | Disposition (change in control) | 3,850,510 | -- | -- | (100%) 3.85M to 0 | |
| 18-Dec-23 6:29 PM View: | Rain Oncology Inc. (RAIN) | 18-Dec-23 | Sale | 40,132 | $1.21 | $48,559.70 | (1%) 3.89M to 3.85M | |
| 18-Dec-23 6:29 PM View: | Rain Oncology Inc. (RAIN) | 15-Dec-23 | Sale | 109,435 | $1.20 | $131,322.00 | (3%) 4.0M to 3.89M | |
| 18-Dec-23 6:29 PM View: | Rain Oncology Inc. (RAIN) | 14-Dec-23 | Sale | 24,406 | $1.21 | $29,531.30 | (< 1%) 4.02M to 4.0M | |
| 13-Oct-23 4:57 PM View: | Rain Oncology Inc. (RAIN) | 13-Oct-23 | Purchase | 131,631 | $0.99 | $130,315.00 | 3% 3.89M to 4.02M | |
| 13-Oct-23 4:57 PM View: | Rain Oncology Inc. (RAIN) | 12-Oct-23 | Purchase | 77,702 | $0.98 | $76,148.00 | 2% 3.82M to 3.89M | |
| 13-Oct-23 4:57 PM View: | Rain Oncology Inc. (RAIN) | 11-Oct-23 | Private Purchase | 74,812 | $0.97 | $72,567.60 | 2% 3.74M to 3.82M | |
| 14-Feb-24 5:25 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 01-Jun-23 | Disposition (other) | 4,394,800 | -- | -- | (100%) 4.39M to 0 | |
| 01-Jun-23 6:46 PM View: | Rain Oncology Inc. (RAIN) | 01-Jun-23 | Purchase | 333,325 | $1.11 | $370,534.00 | 10% 3.41M to 3.74M | |
| 01-Jun-23 6:46 PM View: | Rain Oncology Inc. (RAIN) | 31-May-23 | Purchase | 166,180 | $1.08 | $179,574.00 | 5% 3.24M to 3.41M | |
| 01-Jun-23 6:46 PM View: | Rain Oncology Inc. (RAIN) | 30-May-23 | Private Purchase | 588,768 | $1.03 | $608,655.00 | 22% 2.65M to 3.24M | |
| 30-May-23 8:02 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 25-May-23 | Private Purchase | 50,000 | $1.72 | $86,000.00 | 1% 4.34M to 4.39M | |
| 15-May-23 5:12 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 12-May-23 | Purchase | 6,183 | $1.95 | $12,056.90 | < 1% 4.34M to 4.34M | |
| 15-May-23 5:12 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 11-May-23 | Private Purchase | 38,765 | $1.95 | $75,591.80 | < 1% 4.3M to 4.34M | |
| 10-May-23 7:02 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 10-May-23 | Purchase | 6,774 | $1.95 | $13,209.30 | < 1% 4.29M to 4.3M | |
| 10-May-23 7:02 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 09-May-23 | Purchase | 20,141 | $1.95 | $39,274.90 | < 1% 4.27M to 4.29M | |
| 10-May-23 7:02 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 08-May-23 | Private Purchase | 57,073 | $1.95 | $111,292.00 | 1% 4.22M to 4.27M | |
| 05-May-23 6:52 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 05-May-23 | Purchase | 166,823 | $1.92 | $319,806.00 | 4% 4.05M to 4.22M | |
| 05-May-23 6:52 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 04-May-23 | Purchase | 104,241 | $1.86 | $193,888.00 | 3% 3.94M to 4.05M | |
| 05-May-23 4:37 PM View: | Jounce Therapeutics, Inc. (JNCE) | 03-May-23 | Acquisition (other) Duplicate | 10,000 | $9,737.70 | $97,377,000.00 | < 1% 5.3M to 5.31M | |
| 05-May-23 4:37 PM View: | Jounce Therapeutics, Inc. (JNCE) | 03-May-23 | Disposition (change in control) | 5,300,090 | $1.85 | $9,805,160.00 | (100%) 5.31M to 10.0K | |
| 05-May-23 6:52 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 03-May-23 | Private Purchase | 18,513 | $1.85 | $34,249.10 | < 1% 3.93M to 3.94M | |
| 14-Mar-23 8:39 PM View: | Jounce Therapeutics, Inc. (JNCE) | 14-Mar-23 | Purchase | 20,286 | $1.02 | $20,651.10 | < 1% 5.28M to 5.3M | |
| 14-Mar-23 8:39 PM View: | Jounce Therapeutics, Inc. (JNCE) | 13-Mar-23 | Private Purchase | 65,701 | $0.99 | $65,306.80 | 1% 5.21M to 5.28M | |
| 24-Aug-22 4:02 PM View: | La Jolla Pharmaceutical Co. (LJPC) | 22-Aug-22 | Disposition (change in control) Duplicate | 9,607,930 | $6.23 | $59,857,400.00 | (100%) 9.61M to 0 | |
| 24-Aug-22 8:21 PM View: | La Jolla Pharmaceutical Co. (LJPC) | 22-Aug-22 | Disposition (change in control) Duplicate | 9,607,930 | $6.23 | $59,857,400.00 | (100%) 9.61M to 0 | |
| 01-Dec-21 7:07 PM View: | La Jolla Pharmaceutical Co. (LJPC) | 01-Dec-21 | Market Sale | 177,545 | $3.74 | $663,431.00 | (2%) 9.79M to 9.61M | (2%) |
| 01-Dec-21 7:07 PM View: | La Jolla Pharmaceutical Co. (LJPC) | 30-Nov-21 | Market Sale | 70,342 | $3.95 | $277,612.00 | (< 1%) 9.86M to 9.79M | 3% |
| 01-Dec-21 7:07 PM View: | La Jolla Pharmaceutical Co. (LJPC) | 29-Nov-21 | Market Sale | 193,403 | $4.10 | $793,107.00 | (2%) 10.05M to 9.86M | 7% |
| 26-Nov-21 1:02 PM View: | Aptevo Therapeutics Inc. (APVO) | 23-Nov-21 | Market Sale | 921,336 | $11.25 | $10,368,200.00 | (100%) 921.34K to 0 | (6%) |
| 22-Nov-21 5:26 PM View: | Aptevo Therapeutics Inc. (APVO) | 22-Nov-21 | Market Sale | 255,331 | $7.03 | $1,795,990.00 | (22%) 1.18M to 921.34K | (4%) |
| 22-Nov-21 5:26 PM View: | Aptevo Therapeutics Inc. (APVO) | 19-Nov-21 | Market Sale | 213,800 | $7.59 | $1,622,870.00 | (15%) 1.39M to 1.18M | 4% |
| 19-Nov-21 4:38 PM View: | Odonate Therapeutics, Inc. (ODT) | 19-Nov-21 | Market Sale | 365,289 | $1.92 | $699,930.00 | (3%) 13.13M to 12.77M | < 1% |
| 22-Nov-21 5:26 PM View: | Aptevo Therapeutics Inc. (APVO) | 18-Nov-21 | Market Sale | 369,533 | $8.34 | $3,081,560.00 | (21%) 1.76M to 1.39M | 12% |
| 19-Nov-21 4:38 PM View: | Odonate Therapeutics, Inc. (ODT) | 18-Nov-21 | Market Sale | 1,094,260 | $1.90 | $2,081,880.00 | (8%) 14.23M to 13.13M | < 1% |
| 19-Nov-21 4:38 PM View: | Odonate Therapeutics, Inc. (ODT) | 17-Nov-21 | Market Sale | 1,287,580 | $2.29 | $2,948,750.00 | (8%) 15.51M to 14.23M | 17% |
| 01-Jun-21 6:42 PM View: | La Jolla Pharmaceutical Co. (LJPC) | 01-Jun-21 | Market Purchase | 59,092 | $4.47 | $263,931.00 | < 1% 9.99M to 10.05M | (14%) |
| 01-Jun-21 6:42 PM View: | La Jolla Pharmaceutical Co. (LJPC) | 27-May-21 | Market Purchase | 185,928 | $4.47 | $831,762.00 | 2% 9.8M to 9.99M | (14%) |
| 26-May-21 4:56 PM View: | La Jolla Pharmaceutical Co. (LJPC) | 26-May-21 | Market Purchase | 166,932 | $4.26 | $710,763.00 | 2% 9.64M to 9.8M | (10%) |
| 26-May-21 4:56 PM View: | La Jolla Pharmaceutical Co. (LJPC) | 25-May-21 | Market Purchase | 127,379 | $3.79 | $482,734.00 | 1% 9.51M to 9.64M | 1% |
| 26-May-21 4:56 PM View: | La Jolla Pharmaceutical Co. (LJPC) | 24-May-21 | Market Purchase | 104,403 | $3.68 | $384,234.00 | 1% 9.41M to 9.51M | 4% |
| 23-Dec-20 4:41 PM View: | Odonate Therapeutics, Inc. (ODT) | 23-Dec-20 | Market Purchase | 139,138 | $15.58 | $2,167,850.00 | < 1% 15.38M to 15.51M | 11% |
| 23-Dec-20 4:41 PM View: | Odonate Therapeutics, Inc. (ODT) | 22-Dec-20 | Market Purchase | 74,502 | $14.87 | $1,107,590.00 | < 1% 15.3M to 15.38M | 16% |
| 23-Dec-20 4:41 PM View: | Odonate Therapeutics, Inc. (ODT) | 21-Dec-20 | Market Purchase | 62,144 | $14.58 | $905,767.00 | < 1% 15.24M to 15.3M | 18% |
| 06-Nov-20 4:47 PM View: | Aptevo Therapeutics Inc. (APVO) | 06-Nov-20 | Market Purchase | 174,277 | $22.73 | $3,961,900.00 | 11% 1.59M to 1.76M | |
| 06-Nov-20 4:47 PM View: | Aptevo Therapeutics Inc. (APVO) | 05-Nov-20 | Market Purchase | 625,723 | $18.78 | $11,750,300.00 | 65% 960.0K to 1.59M | |
| 06-Nov-20 4:47 PM View: | Aptevo Therapeutics Inc. (APVO) | 04-Nov-20 | Market Purchase | 636,675 | $14.35 | $9,137,030.00 | 197% 323.32K to 960.0K |